The Recall Desk
ModerateFDA (Drugs)·D-0074-2025·Announced 2024-12-04

Drug Lice Treatment Recalled Due to Manufacturing Practice Violations

Neogen Corporation has voluntarily recalled LICEOUT liquid lice treatment due to manufacturing practice violations. The recall affects 8,328 jugs distributed to institutions.

What this means for you

Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.

Our severity reasoning: FDA Class II voluntary recall due to manufacturing practice violations with no reported illnesses or injuries. The recall is precautionary and addresses process compliance issues rather than a specific identified product hazard.

Plain-English summary

Neogen Corporation has voluntarily recalled LICEOUT, a liquid lice treatment for human use, due to Current Good Manufacturing Practices (CGMP) violations. The recall includes 8,328 jugs distributed through Bob Barker Company, Inc., which supplies institutional facilities.

The Food and Drug Administration classified this as a Class II recall. The recall was initiated on October 8, 2024, and is ongoing.

Affected product includes specific lot numbers (LO09530, LO13412, LO10263, LO11303, LO12153, LO12483, LO13183, LO106024, LO108624, and LO110224) with expiration dates ranging from November 3, 2024, through April 11, 2026. Institutions that received this product should not use it and should contact Neogen Corporation or the FDA for information regarding the recall and available alternatives.

The recalled product

Product
LICEOUT, Liquid Lice Treatment for Human Use, Contents: 128 FL OZ. (3785.4 mL mL) per jug, Distributed By: Bob Barker Company, Inc., 7925 Purfoy Road, Fuquay-Varina, NC 27526. NDC: 53247-124-02
Manufacturer
Neogen Corporation
Category
Drug — Topical Lice Treatment
Hazard
Affected units
8,328

Is your product affected?

Check your packaging against the codes below. If any of them match, the product is part of this recall.

Lot numbers (20)

  • Lot
  • expiry: LO09530
  • exp 11/3/2024
  • LO13412
  • exp 12/7/2024
  • LO10263
  • exp 1/26/2025
  • LO11303
  • exp 5/10/2025
  • LO12153
  • exp 8/3/2025
  • LO12483
  • exp 9/5/2025
  • LO13183
  • exp 11/14/2025
  • LO106024
  • exp 2/29/2026
  • LO108624
  • exp 3/26/2026
  • LO110224

Distribution

Distribution scope not specified by the agency.

Part of a larger recall action

This product is one of 2 recalled by Neogen Corporation under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.

See all 2 products in this recall →

Related recalls

Same manufacturer · Neogen Corporation

See all →

Same hazard · manufacturing defect

See all →